Factor V Leiden and recurrent miscarriage - Prospective outcome of untreated pregnancies

Human Reproduction

Volumn 17, Issue 2, 2002, Pages 442-445

  Rai, R ^a,c   Backos, M ^a   Elgaddal, S ^a   Shlebak, A ^b   Regan, L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Factor V Leiden; Pregnancy outcome; Prospective study; Recurrent miscarriage

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; FOLIC ACID;

ADULT; ALLELE; ANAMNESIS; ARTICLE; BIRTH RATE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; GESTATIONAL AGE; HETEROZYGOTE; HUMAN; NEURAL TUBE DEFECT; OUTCOMES RESEARCH; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL SCREENING; PROSPECTIVE STUDY; RECURRENT ABORTION; RISK ASSESSMENT; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 0036177333     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.2.442     Document Type: Article

References (27)

1. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes
2. First-trimester repeated abortion is not associated with activated protein C resistance
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Activated protein C resistance can be associated with recurrent fetal loss
5. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin
6. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506)
7. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism
8. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
9. The factor V Leiden mutation is not a common cause of recurrent miscarriage
10. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
11. ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies
12. Increased frequency of genetic thrombophilia in women with complications of pregnancy
13. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss
14. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
15. Guidelines on testing for the lupus anticoagulant
16. Prevalence of Factor V Leiden is not increased in women with recurrent miscarriage
17. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?
18. Increased fetal loss in women with heritable thrombophilia
19. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
20. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance
21. Factor V Leiden and acquired activated protein C resistance amongst 1000 women with recurrent miscarriage
22. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss
23. Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion
24. Haemostasis in normal pregnancy
25. Resistance to activated protein C as a basis for venous thrombosis
26. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure
27. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation